Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to NRG Oncology
Related studies linked through entity extraction aliases.
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- Status
- RECRUITING
- Phase
- PHASE3
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2